subject area of
- A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study Journal Articles
- Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study Journal Articles
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE) Journal Articles
-
Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs:
A B ayesian meta‐analysis of survival data Journal Articles - Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial Journal Articles
- Do sulphonylureas still have a place in clinical practice? Journal Articles
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis Journal Articles
- Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study Journal Articles
- Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians Journal Articles
- Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial Journal Articles
- Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease Journal Articles
- Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis Journal Articles
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial Journal Articles
- The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Journal Articles
- Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. Journal Articles